Actionable news
All posts from Actionable news
Actionable news in ARIA: ARIAD Pharmaceuticals, Inc.,

ARIAD Pharmaceuticals' (ARIA) CEO Harvey Berger on Q3 2015 Results - Earnings Call Transcript


Thank you for holding for the ARIAD Pharmaceutical's Third Quarter 2015 Financial Results Conference Call. [Operator Instructions]. At this time, I would now like to introduce Ms. Maria Cantor, ARIAD's Senior Vice President, Corporate Affairs. Please go ahead,

Maria Cantor - SVP, Corporate Affairs and HR

Good morning and thank you for joining us. This morning we report on financial results for the third quarter of 2015 and we provide an update on our corporate developments. With me on this call or Dr. Harvey Berger, our Chairman and Chief Executive Officer, Ed Fitzgerald, our Chief Financial Officer, Dr. Tim Clackson, our President of R&D and our Chief Scientific Officer and Marty Duvall or Chief Commercial Officer. During this call, we will be making forward-looking statements.

Please note that these statements are subject to factors, risks and uncertainties, including those that are detailed in our Form 10-K for the year-ended December 31st, 2014, as well as other SEC filings that may cause actual results to differ materially from the results that are expressed or implied by such statements. Now let me introduce Dr. Berger with our opening...